Anna Ettorre

This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: 4D Pharma Research Limited, Cj Bioscience, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Ettorre. Retrieved from https://idiyas.com/inventor/anna-ettorre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 11)

% Patents Active = 87.5

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

6 out of 47

4D Pharma Research Limited

Years Active: 2021-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12048720 - Compositions comprising bacterial strains (2024-07-30),

2. 11779613 - Compositions comprising a bacterial strain of the genusand uses thereof (2023-10-10),

3. 11660319 - Compositions comprising bacterial strains (2023-05-30),

4. 11446336 - Compositions comprising bacterial strains (2022-09-20),

5. 11419931 - Compositions comprising bacterial strains (2022-08-23),

6. 11419902 - Compositions comprising bacterial strains (2022-08-23),

7. 11123379 - Compositions comprising bacterial strains (2021-09-21),

8. 11007233 - Compositions comprising a bacterial strain of the genusand uses thereof (2021-05-18),

Title: Innovations by Anna Ettorre: Pioneering Solutions for Neurodegenerative Disorders

Introduction

Anna Ettorre, an accomplished inventor based in Aberdeen, GB, has made significant contributions to the field of biotechnology. With a total of eight patents to her name, her work focuses on innovative compositions involving bacterial strains aimed at treating and preventing neurodegenerative disorders.

Latest Patents

Her latest groundbreaking patents include "Compositions comprising bacterial strains," which provide novel solutions for combating neurodegenerative disorders. Additionally, she has developed "Compositions comprising a bacterial strain of the genus and uses thereof," further emphasizing her commitment to advancing medical science through innovative therapeutic approaches.

Career Highlights

Anna has collaborated with notable organizations such as 4D Pharma Research Limited and CJ Bioscience, Inc., where she has played a pivotal role in researching and developing microbiome-based therapies. Her dedication to enhancing the understanding of bacterial strains in relation to health showcases her innovative spirit.

Collaborations

Throughout her career, Anna has had the pleasure of working alongside talented individuals, including her coworkers Imke Elisabeth Mulder and Suaad Ahmed. Together, they have contributed to advancing research in their field and pushing the boundaries of what is possible in treating complex health issues.

Conclusion

Anna Ettorre stands out as a notable figure in innovation, particularly in the realm of biotechnology focused on neurodegenerative disorders. Her impressive portfolio of patents and collaborations with leading companies underscores her commitment to making a difference through scientific research and innovation.

Profile summary based on public USPTO records.